{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T21:02:17Z","timestamp":1771707737754,"version":"3.50.1"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T00:00:00Z","timestamp":1597017600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0237097","type":"journal-article","created":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T17:33:49Z","timestamp":1597080829000},"page":"e0237097","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["Evaluating modified diets and dietary supplement therapies for reducing muscle lipid accumulation and improving muscle function in neurofibromatosis type 1 (NF1)"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9547-3032","authenticated-orcid":true,"given":"Emily R.","family":"Vasiljevski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6132-2554","authenticated-orcid":true,"given":"Peter J.","family":"Houweling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thusitha","family":"Rupasinghe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarneet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1291-0258","authenticated-orcid":true,"given":"Matthew A.","family":"Summers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ute","family":"Roessner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David G.","family":"Little","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron","family":"Schindeler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,8,10]]},"reference":[{"issue":"8","key":"pone.0237097.ref001","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1177\/088307380201700802","article-title":"Neurofibromatosis 1: clinical manifestations and diagnostic criteria","volume":"17","author":"JM Friedman","year":"2002","journal-title":"Journal of child neurology"},{"issue":"2","key":"pone.0237097.ref002","first-page":"161","article-title":"Skeletal muscle and motor deficits in Neurofibromatosis Type 1","volume":"15","author":"MA Summers","year":"2015","journal-title":"Journal of musculoskeletal & neuronal interactions"},{"issue":"4","key":"pone.0237097.ref003","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/j.1365-2133.2008.08949.x","article-title":"Impact of neurofibromatosis 1 upon quality of life in childhood: a cross-sectional study of 79 cases","volume":"160","author":"P Wolkenstein","year":"2009","journal-title":"The British journal of dermatology"},{"issue":"14","key":"pone.0237097.ref004","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1093\/hmg\/ddr149","article-title":"Neurofibromin (Nf1) is required for skeletal muscle development","volume":"20","author":"N Kossler","year":"2011","journal-title":"Hum Mol Genet"},{"issue":"5","key":"pone.0237097.ref005","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1093\/hmg\/ddt515","article-title":"NF1 is a critical regulator of muscle development and metabolism","volume":"23","author":"K Sullivan","year":"2014","journal-title":"Human Molecular Genetics"},{"issue":"4","key":"pone.0237097.ref006","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/hmg\/ddx423","article-title":"Dietary intervention rescues myopathy associated with neurofibromatosis type 1","volume":"27","author":"MA Summers","year":"2018","journal-title":"Human Molecular Genetics"},{"issue":"1","key":"pone.0237097.ref007","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0887-8994(93)90007-Y","article-title":"Infantile idiopathic myopathic carnitine deficiency: treatment with L-carnitine","volume":"9","author":"Y Shapira","year":"1993","journal-title":"Pediatric neurology"},{"issue":"1","key":"pone.0237097.ref008","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1055\/s-2008-1052536","article-title":"Successful carnitine treatment in two siblings having lipid storage myopathy with hypertrophic cardiomyopathy","volume":"16","author":"T Matsuishi","year":"1985","journal-title":"Neuropediatrics"},{"issue":"2","key":"pone.0237097.ref009","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1016\/j.ijcard.2012.05.038","article-title":"Primary carnitine deficiency dilated cardiomyopathy: 28 years follow-up","volume":"162","author":"A Agnetti","year":"2013","journal-title":"International journal of cardiology"},{"issue":"13\u201314","key":"pone.0237097.ref010","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.addr.2008.05.001","article-title":"The mitochondrial cocktail: rationale for combined nutraceutical therapy in mitochondrial cytopathies","volume":"60","author":"MA Tarnopolsky","year":"2008","journal-title":"Advanced drug delivery reviews"},{"key":"pone.0237097.ref011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plipres.2018.08.001","article-title":"Lipid storage myopathies: Current treatments and future directions","volume":"72","author":"ER Vasiljevski","year":"2018","journal-title":"Progress in lipid research"},{"issue":"10","key":"pone.0237097.ref012","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/ng2122","article-title":"Loss of ACTN3 gene function alters mouse muscle metabolism and shows evidence of positive selection in humans","volume":"39","author":"DG MacArthur","year":"2007","journal-title":"Nature genetics"},{"issue":"5","key":"pone.0237097.ref013","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1023\/A:1014587918367","article-title":"Tibialis anterior muscles in mdx mice are highly susceptible to contraction-induced injury","volume":"22","author":"C Dellorusso","year":"2001","journal-title":"Journal of muscle research and cell motility"},{"issue":"1","key":"pone.0237097.ref014","doi-asserted-by":"crossref","first-page":"14143","DOI":"10.1038\/ncomms14143","article-title":"Evidence for ACTN3 as a genetic modifier of Duchenne muscular dystrophy","volume":"8","author":"MW Hogarth","year":"2017","journal-title":"Nature Communications"},{"issue":"2","key":"pone.0237097.ref015","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/gene.10092","article-title":"Expression of Cre Recombinase in the developing mouse limb bud driven by a Prxl enhancer","volume":"33","author":"M Logan","year":"2002","journal-title":"Genesis (New York, NY: 2000)"},{"issue":"7","key":"pone.0237097.ref016","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1101\/gad.862101","article-title":"Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain","volume":"15","author":"Y Zhu","year":"2001","journal-title":"Genes & development"},{"issue":"5","key":"pone.0237097.ref017","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.ajhg.2018.03.009","article-title":"The Effect of ACTN3 Gene Doping on Skeletal Muscle Performance","volume":"102","author":"FC Garton","year":"2018","journal-title":"Am J Hum Genet"},{"key":"pone.0237097.ref018","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/978-1-62703-577-4_4","article-title":"A robust GC-MS method for the quantitation of fatty acids in biological systems","volume":"1055","author":"NS Jayasinghe","year":"2013","journal-title":"Methods in molecular biology (Clifton, NJ)"},{"issue":"8","key":"pone.0237097.ref019","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1002\/bit.24844","article-title":"A quantitative analysis of microalgal lipids for optimization of biodiesel and omega-3 production","volume":"110","author":"IL Olmstead","year":"2013","journal-title":"Biotechnology and bioengineering"},{"key":"pone.0237097.ref020","doi-asserted-by":"crossref","first-page":"1756286419843359","DOI":"10.1177\/1756286419843359","article-title":"Metabolic lipid muscle disorders: biomarkers and treatment","volume":"12","author":"C Angelini","year":"2019","journal-title":"Therapeutic Advances in Neurological Disorders"},{"issue":"S1","key":"pone.0237097.ref021","doi-asserted-by":"crossref","first-page":"e282","DOI":"10.1016\/j.physio.2016.10.359","article-title":"The effect of liver dysfunction on muscle strength in liver disease patients","volume":"102","author":"K Fudeyasu","year":"2016","journal-title":"Physiotherapy"},{"key":"pone.0237097.ref022","article-title":"Reversible weakness and encephalopathy while on long-term valproate treatment due to carnitine deficiency","volume":"2015","author":"A Al-sharefi","year":"2015","journal-title":"BMJ case reports"},{"key":"pone.0237097.ref023","doi-asserted-by":"crossref","first-page":"3232105","DOI":"10.1155\/2018\/3232105","article-title":"Primary Carnitine Deficiency: A Rare, Reversible Metabolic Cardiomyopathy","volume":"2018","author":"S Tomlinson","year":"2018","journal-title":"Case reports in cardiology"},{"issue":"12","key":"pone.0237097.ref024","doi-asserted-by":"crossref","first-page":"785","DOI":"10.4070\/kcj.2013.43.12.785","article-title":"Primary carnitine deficiency and cardiomyopathy","volume":"43","author":"L Fu","year":"2013","journal-title":"Korean circulation journal"},{"issue":"7","key":"pone.0237097.ref025","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1111\/ene.13319","article-title":"Riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency: delayed hypersensitivity reaction and efficacy of low-dose intermittent supplementation","volume":"24","author":"G Vattemi","year":"2017","journal-title":"European journal of neurology"},{"issue":"4","key":"pone.0237097.ref026","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1089\/jmf.2006.9.468","article-title":"L-carnitine stimulates lipolysis via induction of the lipolytic gene expression and suppression of the adipogenic gene expression in 3T3-L1 adipocytes","volume":"9","author":"MS Lee","year":"2006","journal-title":"Journal of medicinal food"},{"key":"pone.0237097.ref027","doi-asserted-by":"crossref","first-page":"40815","DOI":"10.1038\/srep40815","article-title":"Systemic regulation of L-carnitine in nutritional metabolism in zebrafish, Danio rerio","volume":"7","author":"JM Li","year":"2017","journal-title":"Scientific reports"},{"issue":"2","key":"pone.0237097.ref028","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/GIM.0b013e3181614289","article-title":"Acylcarnitine profile analysis","volume":"10","author":"P Rinaldo","year":"2008","journal-title":"Genetics in Medicine"},{"issue":"12","key":"pone.0237097.ref029","first-page":"5968","article-title":"Hydroxylated Long-Chain Acylcarnitines are Biomarkers of Mitochondrial Myopathy","volume":"104","author":"CR Vissing","year":"2019","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"45","key":"pone.0237097.ref030","doi-asserted-by":"crossref","first-page":"e8549","DOI":"10.1097\/MD.0000000000008549","article-title":"Carnitine-acylcarnitine translocase deficiency with c.199-10 T>G and novel c.1A>G mutation: Two case reports and brief literature review","volume":"96","author":"HM Yan","year":"2017","journal-title":"Medicine"},{"key":"pone.0237097.ref031","unstructured":"Wieser T. Carnitine Palmitoyltransferase II Deficiency. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, et al., editors. GeneReviews((R)). Seattle (WA): University of Washington, Seattle University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.; 1993."},{"issue":"1","key":"pone.0237097.ref032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/db12-0466","article-title":"Acylcarnitines: reflecting or inflicting insulin resistance?","volume":"62","author":"MG Schooneman","year":"2013","journal-title":"Diabetes"},{"issue":"8","key":"pone.0237097.ref033","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1093\/hmg\/ddm032","article-title":"Multiple roles for neurofibromin in skeletal development and growth","volume":"16","author":"M Kolanczyk","year":"2007","journal-title":"Hum Mol Genet"},{"issue":"1","key":"pone.0237097.ref034","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ymgme.2007.12.004","article-title":"Generalized metabolic bone disease in Neurofibromatosis type I","volume":"94","author":"N Brunetti-Pierri","year":"2008","journal-title":"Mol Genet Metab"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0249380","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T00:00:00Z","timestamp":1616544000000}}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0237097","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T18:40:39Z","timestamp":1597776039000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0237097"}},"subtitle":[],"editor":[{"given":"Emanuele","family":"Buratti","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,8,10]]},"references-count":34,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,8,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0237097","relation":{"correction":[{"id-type":"doi","id":"10.1371\/journal.pone.0249380","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,10]]}}}